20 June 2013
Keywords: fda, panel, rejects, myotrophin, again, cephalon, chiron
Article | 19 May 1997
Cephalon and Chiron suffered a blow last week when they failed to get apositive approval recommendation for approval of Myotrophin ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.